↓ Skip to main content

Could Valerian Have Been the First Anticonvulsant?

Overview of attention for article published in Epilepsia, October 2004
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
2 news outlets
blogs
1 blog
twitter
2 X users
facebook
1 Facebook page
wikipedia
8 Wikipedia pages

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
56 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Could Valerian Have Been the First Anticonvulsant?
Published in
Epilepsia, October 2004
DOI 10.1111/j.0013-9580.2004.27904.x
Pubmed ID
Authors

Mervyn J Eadie

Abstract

To assess the available evidence for the belief that valerian, highly recommended in the past for treating epilepsy, possessed real anticonvulsant effectiveness.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 2%
United States 1 2%
Unknown 54 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 13 23%
Student > Bachelor 8 14%
Student > Master 7 13%
Researcher 5 9%
Student > Doctoral Student 3 5%
Other 9 16%
Unknown 11 20%
Readers by discipline Count As %
Medicine and Dentistry 12 21%
Agricultural and Biological Sciences 11 20%
Biochemistry, Genetics and Molecular Biology 4 7%
Nursing and Health Professions 4 7%
Pharmacology, Toxicology and Pharmaceutical Science 4 7%
Other 9 16%
Unknown 12 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 December 2023.
All research outputs
#1,271,377
of 26,017,215 outputs
Outputs from Epilepsia
#263
of 5,995 outputs
Outputs of similar age
#1,530
of 78,807 outputs
Outputs of similar age from Epilepsia
#1
of 20 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,995 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.7. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 78,807 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.